T1	Participants 81 100	psoriatic arthritis
T2	Participants 127 135	patients
T3	Participants 469 532	patients with psoriatic arthritis, in stable low disease state.
T4	Participants 1025 1113	Seventy-two patients were invited to participate, of which 57 were found to be eligible.
